Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 10-Aug-23 4:26 PM View:  | Mirati Therapeutics, Inc. (MRTX) | 09-Aug-23 | Grant | 22,297 | $37.00 | $824,989.00 | 28% 80.02K to 102.31K | |
| 02-Jun-23 7:15 PM View: | Mirati Therapeutics, Inc. (MRTX) | 02-Jun-23 | Sale | 4,647 | $37.06 | $172,218.00 | (5%) 84.66K to 80.02K | |
| 24-Jan-23 4:00 PM View: | Mirati Therapeutics, Inc. (MRTX) | 20-Jan-23 | Grant | 26,864 | -- | -- | 46% 57.8K to 84.66K | |
| 03-Jun-22 5:56 PM View: | Mirati Therapeutics, Inc. (MRTX) | 01-Jun-22 | Grant | 57,798 | -- | -- | 100% 0 to 57.8K | |
| 11-Mar-22 4:12 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 11-Mar-22 | Disposition (other) | 37,208 | -- | -- | (100%) 37.21K to 0 | |
| 05-Jan-22 10:00 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 03-Jan-22 | Grant | 21,462 | -- | -- | 144% 14.9K to 36.37K | |
| 02-Apr-21 8:10 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 16-Mar-21 | Payment of Exercise | 4,356 | $76.10 | $331,492.00 | (23%) 19.26K to 14.9K | |
| 02-Apr-21 8:10 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 16-Mar-21 | Option Exercise | 12,600 | -- | -- | 189% 6.66K to 19.26K | |
| 03-Mar-21 9:33 PM View: | Arena Pharmaceuticals, Inc. (ARNA) | 01-Mar-21 | Grant | 6,660 | -- | -- | 100% 0 to 6.66K | |
| 24-Feb-20 8:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 22-Feb-20 | Payment of Exercise | 4,508 | $21.83 | $98,409.60 | (3%) 130.68K to 126.17K | |
| 24-Feb-20 8:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 22-Feb-20 | Option Exercise | 11,392 | -- | -- | 10% 119.28K to 130.68K | |
| 18-Feb-20 4:15 PM View: | Halozyme Therapeutics, Inc. (HALO) | 14-Feb-20 | Payment of Exercise | 2,700 | $21.10 | $56,970.00 | (2%) 121.98K to 119.28K | |
| 18-Feb-20 4:15 PM View: | Halozyme Therapeutics, Inc. (HALO) | 14-Feb-20 | Option Exercise | 7,809 | -- | -- | 7% 114.17K to 121.98K | |
| 13-Feb-20 6:38 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Feb-20 | Payment of Exercise | 3,894 | $20.00 | $77,880.00 | (3%) 118.07K to 114.17K | |
| 13-Feb-20 6:38 PM View: | Halozyme Therapeutics, Inc. (HALO) | 12-Feb-20 | Option Exercise | 11,262 | -- | -- | 11% 106.81K to 118.07K | |
| 04-Feb-20 4:21 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-20 | Payment of Exercise | 8,275 | $19.21 | $158,963.00 | (7%) 115.08K to 106.81K | |
| 04-Feb-20 4:21 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-20 | Option Exercise | 23,119 | -- | -- | 25% 91.96K to 115.08K | |
| 17-Jun-19 8:19 AM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Jun-19 | Payment of Exercise | 3,408 | $15.73 | $53,607.80 | (4%) 95.37K to 91.96K | |
| 17-Jun-19 8:19 AM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Jun-19 | Option Exercise | 6,875 | -- | -- | 8% 88.5K to 95.37K | |
| 22-Feb-19 7:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 22-Feb-19 | Payment of Exercise | 3,939 | $16.81 | $66,214.60 | (4%) 92.43K to 88.5K | |
| 22-Feb-19 7:03 PM View: | Halozyme Therapeutics, Inc. (HALO) | 22-Feb-19 | Option Exercise | 11,392 | -- | -- | 14% 81.04K to 92.43K | |
| 15-Feb-19 5:33 PM View: | Halozyme Therapeutics, Inc. (HALO) | 14-Feb-19 | Payment of Exercise | 2,700 | $16.54 | $44,658.00 | (3%) 83.74K to 81.04K | |
| 15-Feb-19 5:33 PM View: | Halozyme Therapeutics, Inc. (HALO) | 14-Feb-19 | Option Exercise | 7,809 | -- | -- | 10% 75.93K to 83.74K | |
| 05-Feb-19 4:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-19 | Payment of Exercise | 8,317 | $16.12 | $134,070.00 | (10%) 84.25K to 75.93K | |
| 05-Feb-19 4:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-19 | Option Exercise | 23,119 | -- | -- | 38% 61.13K to 84.25K | |
| 18-Jun-18 4:23 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Jun-18 | Payment of Exercise | 3,254 | $19.02 | $61,891.10 | (5%) 64.39K to 61.13K | |
| 18-Jun-18 4:23 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Jun-18 | Option Exercise | 6,875 | -- | -- | 12% 57.51K to 64.39K | |
| 23-Feb-18 5:13 PM View: | Halozyme Therapeutics, Inc. (HALO) | 22-Feb-18 | Payment of Exercise | 3,939 | $19.28 | $75,943.90 | (6%) 61.45K to 57.51K | |
| 23-Feb-18 5:13 PM View: | Halozyme Therapeutics, Inc. (HALO) | 22-Feb-18 | Option Exercise | 11,392 | -- | -- | 23% 50.06K to 61.45K | |
| 05-Feb-18 4:25 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-18 | Payment of Exercise | 8,265 | $18.37 | $151,828.00 | (14%) 58.32K to 50.06K | |
| 05-Feb-18 4:25 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-18 | Option Exercise | 23,120 | -- | -- | 66% 35.2K to 58.32K | |
| 16-Jun-17 4:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Jun-17 | Payment of Exercise | 2,583 | $13.05 | $33,708.20 | (7%) 37.78K to 35.2K | |
| 16-Jun-17 4:10 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Jun-17 | Option Exercise | 6,875 | -- | -- | 22% 30.91K to 37.78K | |
| 06-Feb-17 7:01 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-17 | Payment of Exercise | 9,085 | $12.26 | $111,382.00 | (23%) 39.99K to 30.91K | |
| 06-Feb-17 7:01 PM View: | Halozyme Therapeutics, Inc. (HALO) | 03-Feb-17 | Option Exercise | 23,120 | -- | -- | 137% 16.88K to 39.99K | |
| 16-Jun-16 4:12 PM View: | Halozyme Therapeutics, Inc. (HALO) | 15-Jun-16 | Option Exercise | 6,875 | -- | -- | 69% 10.0K to 16.88K | |
| 24-Aug-15 8:46 AM View: | Halozyme Therapeutics, Inc. (HALO) | 20-Aug-15 | Market Purchase | 10,000 | $17.24 | $172,384.00 | 100% 0 to 10.0K |